Amanote Research

Amanote Research

    RegisterSign In

Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors and Migraine: Should Cochrane Close the Door?

Journal of Biomedical Science and Engineering
doi 10.4236/jbise.2018.114006
Full Text
Open PDF
Abstract

Available in full text

Date

January 1, 2018

Authors
Daniel Shevel
Publisher

Scientific Research Publishing, Inc.


Related search

Selective Serotonin Reuptake Inhibitors.

BMJ
1992English

Selective Serotonin Reuptake Inhibitors for Fibromyalgia Syndrome

Sao Paulo Medical Journal
Medicine
2015English

Selective Serotonin Reuptake Inhibitors (SSRIs) for Stroke

2011English

Pmh16 - The Prescription Patterns of Selective Serotonin (Norepinephrine) Reuptake Inhibitors in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Hyponatremia Associated With Selective Serotonin Reuptake Inhibitors

Internal Medicine
Internal MedicineMedicine
2005English

Selective Serotonin Reuptake Inhibitors Induced Serotonin Syndrome –A Case Report

International Journal of Hospital Pharmacy
2017English

Selective Serotonin Reuptake Inhibitors and Operative Bleeding Risk

Journal of Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2016English

Selective Serotonin Reuptake Inhibitors (SSRIs) for Stroke Recovery

Cochrane Database of Systematic Reviews
2012English

Serotonin Noradrenaline Reuptake Inhibitors (SNRIs)

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy